Krishnan Mahesh
- SEC CIK
- 0001866746
In the past year, 1 open-market sale filing worth $547.8K and no purchases.
Current role at each company
- HALO Halozyme Therapeutics, Inc.Directoras of Jun 30, 2026
- KDNY Chinook Therapeutics, Inc.Directoras of Aug 11, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $547.8K
- 1 filing
- Net
- −$547.8K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Krishnan Mahesh as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
HALO Halozyme Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 (view filing) | Jun 29 | 1 day | Krishnan MaheshDirector | SSale | −7.30K | $75.00 | −$547.8K | −33.6%14.5K after | 10b5-1 |
KDNY Chinook Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 4, 2023 (view filing) | Apr 4 | Same day | Krishnan MaheshDirector | SSale | −924 | $23.01 | −$21.3K | −42.0%1.27K after | 10b5-1 |